View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 8, 2018

Pfizer and Swansea University to create innovation hub

Pfizer and Swansea University have formalised a collaboration aimed at improving the health and wellbeing of the people of South West Wales.

By Ellen Daniel

Pfizer and Swansea University have formalised a collaboration aimed at improving the health and wellbeing of the people of South West Wales.

Speaking to delegates during a keynote speech at this year’s BioWales conference, spokespeople from both Pfizer and the University of Swansea confirmed that the collaboration has been formalised, and that they ‘look forward to working together to share knowledge and experience’.

Originally launched at the 2017 conference, the collaboration will involve Pfizer setting up an innovation hub at the School of Management on Swansea University’s £450m Bay Campus. The aim of the hub is to share knowledge, skills and expertise to develop a health system that works with industry, the NHS and academia to improve healthcare in the region. The pharmaceutical giant will also work with academics from the Institute of Life Science at Swansea University’s Singleton Campus medical school.

The collaboration will incorporate ‘a range of therapeutic and technology-based interventions that will be studied through the collection of real-world data’.

“Our aim is to develop innovative approaches to improve patient outcomes, support long-term sustainability of the NHS and maintain a thriving life sciences industry in the UK,” said Pfizer UK managing director Erik Nordkamp.

“Our aim is to develop innovative approaches to improve patient outcomes, support long-term sustainability of the NHS and maintain a thriving life sciences industry in the UK.”

“With Swansea University, we recognise South West Wales as a region with the potential to be at the forefront of excellence in healthcare service delivery, research, education and innovation.”

The collaboration will also help deliver elements of the £1.3bn Swansea Bay City Region City Deal ─ a project funded by public and private investors aimed at strengthening the health, energy and manufacturing sectors in Swansea and the surrounding areas.

“One of the aims of the City Deal is to create a ‘living laboratory’ in this region for health, wellbeing and life sciences,” said Swansea University vice-president Professor Marc Clement. “This regional vision is strongly aligned with the UK Government’s recent Life Science Industrial Strategy.

“We see this collaboration with Pfizer as a real opportunity to operationalise our vision and aims with purpose and pace.”

In 2016, technology company Fujitsu opened an education innovation hub on the Swansea Bay Campus. In the same year the Bevan Commission, which provides guidance to the Minister for Health and Social Services on health and healthcare in Wales, relocated its headquarters to the campus.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU